Search Results

There are 47526 results for: content related to: High doses of recombinant α-interferon or γ-interferon for chronic hepatitis C: A randomized, controlled trial

  1. Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha

    British Journal of Haematology

    Volume 78, Issue 2, June 1991, Pages: 210–216, P. v. Wussow, D. Jakschies, M. Freund, R. Hehlmann, F. Brockhaus, H. Hochkeppel, M. Horisberger and H. Deicher

    Version of Record online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1991.tb04418.x

  2. Epitopes recognized by neutralizing therapy-induced human anti-interferon-α antibodies are localized within the N-terminal functional domain of recombinant interferon-α2

    European Journal of Immunology

    Volume 26, Issue 9, September 1996, Pages: 2155–2159, Klaus-Ulrich Nolte, Gero Günther and Peter von Wussow

    Version of Record online : 17 NOV 2005, DOI: 10.1002/eji.1830260929

  3. Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

    Hepatology

    Volume 17, Issue 3, March 1993, Pages: 389–394, Dr. Ching-Lung Lai, Johnson Y. N. Lau, Pui-Chee Wu, Henry Ngan, Hau-Tim Chung, Stuart J. Mitchell, Timothy J. Corbett, Anthony W. C. Chow and Hsiang-Ju Lin

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840170307

  4. The effects of interferon-α on the proliferation of CML progenitor cells in vitro are not related to the precise position of the M-BCR breakpoint

    British Journal of Haematology

    Volume 77, Issue 2, February 1991, Pages: 165–171, C. Dowding, A-P. Guo, D. Maisin, M. Y. Gordon and J. M. Goldman

    Version of Record online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1991.tb07972.x

  5. You have free access to this content
    Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover

    Hepatology

    Volume 28, Issue 1, July 1998, Pages: 245–252, Prof. med. Stefan Zeuzem, Jürgen M. Schmidt, Jung-hun Lee, Michael von Wagner, Gerlinde Teuber and W. Kurt Roth

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510280132

  6. The effect of interferon on experimental metastases in immunocompetent and immunodeficient mice

    International Journal of Cancer

    Volume 37, Issue 4, 15 April 1986, Pages: 563–568, P. Ramani, I. R. Hart and F. R. Balkwill

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910370415

  7. Synergistic antiproliferative effects of glucocorticoids and interferon-α on some lymphoid cell lines

    Journal of Cellular Physiology

    Volume 134, Issue 1, January 1988, Pages: 85–92, Keith R. F. Elliott, Gerald L. Princler, Walter J. Urba and Connie R. Faltynek

    Version of Record online : 4 FEB 2005, DOI: 10.1002/jcp.1041340110

  8. Growth-inhibitory activity of interferon-beta against human colorectal carcinoma cell lines

    International Journal of Cancer

    Volume 43, Issue 3, 15 March 1989, Pages: 526–530, Vicky L. Y. Wong, Dave J. Rieman, Lori Aronson, Barbara J. Dalton, Russell Greig and Mario A. Anzano

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910430331

  9. Immune response products alter CNS acitivity: Interferon modulates central opioid function

    Journal of Neuroscience Research

    Volume 19, Issue 1, January 1988, Pages: 130–139, N. Dafny, J. R. Lee and P. M. Dougherty

    Version of Record online : 11 OCT 2004, DOI: 10.1002/jnr.490190118

  10. Human leukocyte interferon alpha: Structure, pharmacology, and therapeutic applications

    Medicinal Research Reviews

    Volume 15, Issue 5, September 1995, Pages: 445–478, G. C. Viscomi, M. Grimaldi, E. Palazzini and S. Silvestri

    Version of Record online : 18 SEP 2006, DOI: 10.1002/med.2610150504

  11. Recombinant interferon-γ inhibits the mitogenic effect of platelet-derived growth factor at a level distal to the growth factor receptor

    Journal of Cellular Physiology

    Volume 134, Issue 3, March 1988, Pages: 396–404, M. Hosang

    Version of Record online : 4 FEB 2005, DOI: 10.1002/jcp.1041340310

  12. Recombinant human leukocyte interferon-α 2b stimulates the synthesis and release of a 90k tumor-associated antigen in human breast cancer cells

    International Journal of Cancer

    Volume 42, Issue 2, 15 August 1988, Pages: 182–184, S. Iacobelli, G. Scambia, C. Natoli, P. Benedetti Panici, G. Baiocchi, L. Perrone and S. Mancuso

    Version of Record online : 18 JUL 2006, DOI: 10.1002/ijc.2910420207

  13. Interleukin 2 and interferon-γ affect human B cells at different stages of activation

    APMIS

    Volume 97, Issue 1-6, January 1989, Pages: 200–206, JUHA PUNNONEN and MATTI K. VILJANEN

    Version of Record online : 15 AUG 2009, DOI: 10.1111/j.1699-0463.1989.tb00778.x

  14. Interferon-α prevents endotoxin-induced mortality in mice

    European Journal of Immunology

    Volume 22, Issue 12, December 1992, Pages: 3097–3101, Shie-Pon Tzung, Thomas C. Mahl, Peter Lance, Valerie Andersen and Stefan A. Cohen

    Version of Record online : 23 NOV 2005, DOI: 10.1002/eji.1830221211

  15. Characterization of the human type I interferon receptor by ligand blotting

    European Journal of Immunology

    Volume 18, Issue 12, December 1988, Pages: 2009–2014, Michael Schwabe, Gerald L. Princler and Connie R. Faltynek

    Version of Record online : 1 DEC 2005, DOI: 10.1002/eji.1830181221

  16. Sequential therapy with recombinant interferons gamma and alpha in patients with unfavorable prognosis of chronic myelocytic leukemia: Clinical responsiveness to recombinant ifn-α correlates with the degree of receptor down-regulation

    International Journal of Cancer

    Volume 43, Issue 2, 15 February 1989, Pages: 235–240, H. H. Bartsch, K. Pfizenmaier, A. Hanusch, P. Scheurich, U. Ücer and G. A. Nagel

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910430211

  17. You have free access to this content
    Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignancies

    Cancer

    Volume 65, Issue 6, 15 March 1990, Pages: 1325–1328, Giovanni Scambia, Pierluigi Benedetti Panici, Stefano Iacobelli, Gabriela Baiocchi, Francesco Battaglia, Lidia Perrone, Carla Sonsini, Gabriella Ferrandina, Clara Natoli and Salvatore Mancuso

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19900315)65:6<1325::AID-CNCR2820650613>3.0.CO;2-J

  18. Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration

    Clinical Pharmacology & Therapeutics

    Volume 37, Issue 1, January 1985, Pages: 85–88, Richard A Smith, Forbes Norris, Darryl Palmer, Leon Bernhardt and Robert J Wills

    Version of Record online : 9 JAN 1985, DOI: 10.1038/clpt.1985.16

  19. You have free access to this content
    Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-α and interleukin-2 on natural killer cell function against tumor cell lines

    Cancer

    Volume 63, Issue 1, 1 January 1989, Pages: 83–89, Carlos S. Alvarado, Harry W. Findley, Wing C. Chan, Robert S. Hnath, Aly Abdel-Mageed, Ray C. Pais, Michael H. Kutner and Abdelsalam H. Ragab

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19890101)63:1<83::AID-CNCR2820630114>3.0.CO;2-A

  20. You have free access to this content
    Induction and increase of HLA-DR antigen expression by immune interferon on ML-3 cell line enhances the anti-HLA-DR immunotoxin activity

    Clinical & Experimental Immunology

    Volume 82, Issue 2, November 1990, Pages: 214–220, M. CHIRON, J. P. JAFFREZOU, P. CARAYON, C. BORDIER, F. ROUBINET, C. XAVIER, M. BRANDELY and G. LAURENT

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2249.1990.tb05429.x